< Terug naar vorige pagina


Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations

Tijdschriftbijdrage - Tijdschriftartikel

Sildenafil, a phosphodiesterase 5 inhibitor with a vasodilatory and anti-remodeling effect, has been investigated concerning various conditions during pregnancy. Per indication, we herein review the rationale and the most relevant experimental and clinical studies, including systematic reviews and meta-analyses, when available. Indications for using sildenafil during the second and third trimester of pregnancy include maternal pulmonary hypertension, preeclampsia, preterm labor, fetal growth restriction, oligohydramnios, fetal distress, and congenital diaphragmatic hernia. For most indications, the rationale for administering prenatal sildenafil is based on limited, equivocal data from in vitro studies and rodent disease models. Clinical studies report mild maternal side effects and suggest good fetal tolerance and safety depending on the underlying pathology.
Tijdschrift: International Journal Of Environmental Research And Public Health
ISSN: 1661-7827
Issue: 18
Volume: 19
Jaar van publicatie:2022